Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02747797
Title Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors eresa Helsten, MD
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST